Dr Jeffrey Cummings: key facts
- Kind of voice
- Academic
- Role
- world-leading dementia researcher
- Quoted on
- Dementia
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“Every year, world‑leading dementia researcher Dr Jeffrey Cummings releases a global snapshot of Alzheimer's trials – and the 2026 update has just been published.”
What Dr Jeffrey Cummings has said
“Anti‑amyloid medicines such as lecanemab and donanemab have been a crucial breakthrough. They've shown that directly targeting the disease's process can slow decline. But they are only the beginning of what people with Alzheimer's will ultimately need.”
University of Nevada · Dementia · 27 Aug 2026 · Slow Alzheimer’s diagnoses ‘mean UK patients missing out on experimental treatments’ ↗
Where Dr Jeffrey Cummings has been quoted
- Global snapshot of Alzheimer’s research offers new hopealzheimersresearchuk.org · 30 Sept 2026
- Slow Alzheimer’s diagnoses ‘mean UK patients missing out on experimental treatments’theguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.